Will New Jersey pharmaceutical manufacturing jobs rise YoY?
One-OffMacro & EconomyBusiness & Corporate7mo
KalshiCheck availabilityKYC required2% feeVerified resolution dataFairly calibratedCurrent implied probability
No 96%
Market quality
≤49 / 100
Low quality24h Volume
—
Liquidity
$2K
Low liquidityBid / Ask
8.0% / 9.0%
Spread
1.0 pt
Tight spreadMarket data
Updated 3 minutes ago
Aug 18, 26, 6:00 PM UTCApr 30, 27, 1:59 PM UTC
Trends
Related Markets
Related questions for context, not a comparison of equivalent contracts.
Will North Carolina pharmaceutical manufacturing jobs rise YoY?
KalshiWill Oregon semiconductor manufacturing jobs rise YoY?
KalshiWill Minnesota medical-device manufacturing jobs rise YoY?
KalshiWill US translator jobs stay stable based on 2026 data (likely to be published Q1 2027)?
Manifold MarketsISM Manufacturing PMI - September 2026
PolymarketWill Goldman Sachs fire its banking analysts that took PE jobs?
Manifold MarketsRules
If BLS reports that New Jersey’s annual-average employment in Pharmaceutical and Medicine Manufacturing for 2026 is above 30,300 jobs, then the market resolves to Yes.
Settles via:Bureau of Labor Statistics
- The Underlying is BLS series SMU34000003232540001, All Employees in Pharmaceutical and Medicine Manufacturing in New Jersey, measured in thousands and not seasonally adjusted.
- The 30.3 thousand threshold is fixed and will not change if BLS later revises its 2025 value.
Frequently asked questions
- What are the current odds for Will New Jersey pharmaceutical manufacturing jobs rise YoY??
- Kalshi prices No at 96% as of September 8, 2026.
- When does Will New Jersey pharmaceutical manufacturing jobs rise YoY? resolve?
- Will New Jersey pharmaceutical manufacturing jobs rise YoY? is scheduled to resolve on April 30, 2027.
- How is Will New Jersey pharmaceutical manufacturing jobs rise YoY? settled?
- Kalshi settles this market as follows: If BLS reports that New Jersey’s annual-average employment in Pharmaceutical and Medicine Manufacturing for 2026 is above 30,300 jobs, then the market resolves to Yes.